In addition, we do not see the same magnitude of cardiovascular risk reduction from equivalent weight loss from calorie restriction. In a published expert reaction to the SELECT trial, Tricia Tan, consultant in diabetes, endocrinology and metabolic medicine at Imperial College London and NHS Trust, highlighted the subsequent implication for National Institute for Health and Care Excellence (NICE) guidance, which currently recommends stopping semaglutide treatment in patients who have not lost more than 5% of weight after six months
Weve seen major insurers like Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealthcare, and Cigna increasingly cover FDA-approved weight loss medications
doi: 10.1186/gm367
The following antibodies were used: cytokeratin 7 (CK7/KRT7) (Abcam, ab181598, 1:1000), CYP3A4 (Invitrogen Antibodies, MA5-17064, 1:1000), desmin (R&D Systems, AF3844, 1:20), and albumin (Fortis Life Sciences, A80-129 A, 1:1000)
For the last four weeks, one capsule was given orally three times daily
It belongs to the GLP-1 receptor agonist class of drugs and works by mimicking a natural hormone involved in appetite regulation and glucose metabolism
